[ad_1] Acer Therapeutics (NASDAQ: ACER) has filed a New Drug Application (NDA) with the FDA for approval of EDSIVO (celiprolol) for the treatment of Ehlers-Danlos Vascular Syndrome (VEDS), a tissue condition connective …
Read More »Acer launches US marketing application for Edsivo in connective tissue disorders – Acer Therapeutics Inc. (NASDAQ: ACER)
